157 related articles for article (PubMed ID: 24122202)
1. Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis.
Wang L; Liu Z; Jing P; Shao L; Chen L; He X; Gong W
Tumour Biol; 2014 Feb; 35(2):1649-52. PubMed ID: 24122202
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility.
Bilbao-Aldaiturriaga N; Askaiturrieta Z; Granado-Tajada I; Goričar K; Dolžan V; For The Slovenian Osteosarcoma Study Group ; Garcia-Miguel P; Garcia de Andoin N; Martin-Guerrero I; Garcia-Orad A
Pediatr Res; 2016 Oct; 80(4):472-9. PubMed ID: 27438225
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the MDM2 gene and risk of malignant bone tumors: a meta-analysis.
Tang J; Shen L; Song S; An Z; Zhang C
Tumour Biol; 2014 Jan; 35(1):779-84. PubMed ID: 23979978
[TBL] [Abstract][Full Text] [Related]
4. Letter regarding Wang et al. entitled "Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systematic review and meta-analysis".
Bilbao-Aldaiturriaga N; Martin-Guerrero I; Garcia-Orad A
Tumour Biol; 2014 Jul; 35(7):6179. PubMed ID: 24682904
[No Abstract] [Full Text] [Related]
5. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
[TBL] [Abstract][Full Text] [Related]
6. Letter regarding Wang et al. entitled "Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis".
Liu G; Xu W; Hao Y; Xu Z
Tumour Biol; 2014 Apr; 35(4):3943-4. PubMed ID: 24363062
[No Abstract] [Full Text] [Related]
7. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival.
Toffoli G; Biason P; Russo A; De Mattia E; Cecchin E; Hattinger CM; Pasello M; Alberghini M; Ferrari C; Scotlandi K; Picci P; Serra M
Clin Cancer Res; 2009 May; 15(10):3550-6. PubMed ID: 19451596
[TBL] [Abstract][Full Text] [Related]
8. Association of FGFR3 and MDM2 gene nucleotide polymorphisms with bone tumors.
Naumov VA; Generozov EV; Solovyov YN; Aliev MD; Kushlinsky NE
Bull Exp Biol Med; 2012 Oct; 153(6):869-73. PubMed ID: 23113306
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
[TBL] [Abstract][Full Text] [Related]
10. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
Kong Q; Li P; Tian Q; Ha MW
Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
[TBL] [Abstract][Full Text] [Related]
11. Association between MDM2 rs2279744, MDM2 rs937283, and p21 rs1801270 polymorphisms and retinoblastoma susceptibility.
Cao Q; Wang Y; Song X; Yang W
Medicine (Baltimore); 2018 Dec; 97(49):e13547. PubMed ID: 30544467
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
Xue Z; Zhu X; Teng Y
Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
[TBL] [Abstract][Full Text] [Related]
13. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
14. MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis.
Wang LH; Wang X; Xu WT; Hu YL
Tumour Biol; 2014 Apr; 35(4):3167-70. PubMed ID: 24293392
[TBL] [Abstract][Full Text] [Related]
15. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
Liu GY; Jiang DK; Shen SQ; Yu L
Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
[TBL] [Abstract][Full Text] [Related]
16. The effects of common variants in MDM2 and GNRH2 genes on the risk and survival of osteosarcoma in Han populations from Northwest China.
Feng W; Wang Z; Feng D; Zhu Y; Zhang K; Huang W
Sci Rep; 2020 Sep; 10(1):15939. PubMed ID: 32994424
[TBL] [Abstract][Full Text] [Related]
17. Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis.
Zou X; Zhang Y; Zhang L; Li J; Zhu C; Cheng Q; Zhou J; Chen Y
Medicine (Baltimore); 2018 Dec; 97(49):e13273. PubMed ID: 30544386
[TBL] [Abstract][Full Text] [Related]
18. Murine double minute 2 rs2279744 polymorphism and hepatocellular carcinoma risk in East Asians: a meta-analysis.
Liu Y; Kuang S; Zheng J; Zheng J; Jin H; Chen S; Jian Z
Tumour Biol; 2014 Feb; 35(2):961-5. PubMed ID: 24061636
[TBL] [Abstract][Full Text] [Related]
19. The association of MDM2 c.346G>A genetic variant with the risk of osteosarcoma in Chinese.
Hu Z; Li N; Xie X; Jiang R
Genet Test Mol Biomarkers; 2015 Feb; 19(2):108-11. PubMed ID: 25551700
[TBL] [Abstract][Full Text] [Related]
20. Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.
Luan L; Wang H; Zhao B; Wang F; Shi J; Xu X
Pathol Res Pract; 2019 Sep; 215(9):152538. PubMed ID: 31326197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
